Format

Send to

Choose Destination
Mol Interv. 2004 Oct;4(5):254-7.

Combating atherosclerosis with LXR alpha and PPAR alpha agonists: is rational multitargeted polypharmacy the future of therapeutics in complex diseases?

Author information

1
Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
PMID:
15471908
DOI:
10.1124/mi.4.5.5
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center